Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FDA Bypass Budget, Separation From Ag Approps Suggested By Hatch

This article was originally published in The Gray Sheet

Executive Summary

A proposal that would allow FDA to submit its budget request directly to the congressional panels responsible for funding the agency currently is being explored in the Senate by Sens. Orrin Hatch (R-Utah) and Tom Harkin (D-Iowa)

You may also be interested in...

SUD Regulations Mulled In Senate; Hospitals May Not Be Complying

Senate HELP Committee Chairman Edward Kennedy (D-Mass.) supports efforts to provide stronger control of reprocessed single-use medical devices (SUDs), but he has not committed to folding tighter requirements for reprocessors in the conference report on the Bioterrorism Preparedness Act of 2001 (S 1795)

Long Hot Summer For Novel Drug Reviews Forecast At US FDA

Submission surge in late 2019 means a spike in late summer 2020 user fee goals, including 16 novel agents in August alone.




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts